Vext Science, Inc.
CA$0.25+CA$0.02 (+6.52%)
Vext Science, Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.75% below the high.
OTC · SNNVF · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Sunniva Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Sunniva Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Sunniva Inc. is a fully integrated cannabis enterprise that specializes in the comprehensive development of therapeutic cannabis solutions, from cultivation and production to final distribution, primarily serving markets in Canada and the United States. The company organizes its operations into three distinct areas: Patient Counselling, Merchandising, and Cultivation & Extraction. Its product line is marketed under specific brand names, including Sun Fire, Kyndness, and Herbella. Originally founded in 2014 as Sunniva Holdings Corp., the firm officially adopted the name Sunniva Inc. in August 2017. The company's headquarters are situated in Vancouver, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:54 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2018 |
|---|
| Apr 30, 2018 |
| -$0.12 |
| $12.64M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.25+CA$0.02 (+6.52%)
Vext Science, Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.75% below the high.
$0.26-$0.00 (-0.11%)
C21 Investments Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.71% below the high.
$0.07$0.00 (0.0%)
Atlas Energy Corp.’s quoted price sits in the lower half of its reported 52-week range, 56.66% below the high.
$0.05$0.00 (0.0%)
MariMed Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.88% below the high.
CA$0.18-CA$0.01 (-5.26%)
1CM Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.0% below the high.
$0.03$0.00 (0.0%)
Elixxer Ltd.’s quoted price sits in the lower half of its reported 52-week range, 58.12% below the high.
$0.00$0.00 (0.0%)
BellRock Brands Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
TransCanna Holdings Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.